Global Artificial Insemination Market By Type (Intrauterine, Intracervical, Intravaginal, Intratubal), By Source (AIH-Husband and AID-Donor), By End-Use, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Artificial Insemination Market Overview

The global market for artificial insemination was worth USD 1.93 Billion in 2021. It is expected to grow at an 8.9% CAGR between 2023 to 2032.

The WHO estimates that around 10% of women are directly and indirectly affected by infertility. The National Institutes of Health also reported that around 12% of couples of reproductive age are affected by infertility.

Global Artificial Insemination Market Scope:

Type Analysis

Intuitrine insemination accounted for the largest market share in 2021 accounting for over 70% share of the global revenue, and it is expected to maintain its position. This segment is expected to grow the fastest over the forecast period. This method of insemination provides the best chance for successful infertility treatment. It is also non-invasive. The second largest segment is intravaginal (IVI). IVI can be done at home or in fertility clinics. It is particularly preferred for surrogacy and donor-insemination cases.

Source Analysis

The market was led by Artificial Insemination by Husband (AIH). This market is expected to see the fastest CAGR during the forecast period. Couples with non-viable Sperm may choose donor insemination (AID) as an alternative. AID can be used by single women and couples of the same sex. Donor insemination is safe because sperm banks should provide extensive family history and personal medical information to donors.

End-Use Analysis

In 2021, fertility clinics held the largest market share and will likely be the fastest-growing segment of the end-use market over the forecast period. Due to increasing infertility rates around the globe, the number of medical centers that offer infertility treatment services has increased in recent years. Fertility clinics can perform all types of artificial insemination procedures.

Key Market Segments:

By Type

• Intrauterine
• Intracervical
• Intravaginal
• Intratubal

By Source

• AIH-Husband
• AID-Donor

By End-Use

• Fertility Clinics & Other Facilities
• Home

Market Dynamics:

The rate of infertility around the globe is increasing due to more people getting diseases such as erectile dysfunction (ED) and Polycystic Ovary Syndromes (PCOS). Problems can be caused by changes in lifestyles and because more women are working later in life. Stress, alcohol consumption, lifestyle changes, and a decrease in sperm movement can all make it difficult for men to get pregnant. Artificial insemination is a growing market driven by infertility among both men and women.

Artificial insemination must work if you know the distance a sperm has to travel to fertilize an egg. You can choose the type of insemination based on the reasons why the woman is unable to get pregnant. Her age is the most important factor in determining if a woman can get pregnant naturally or with assistance. The likelihood of a woman having children after the age of 30 is usually lower. People who are unable to have children in their 40s and 50s are the highest.

Women over 35 years old are considered to be in their “advanced fertility age,” so they should be checked and treated as soon as possible. Because it is safer for patients, standardizing procedures in different countries can make them more popular. According to government regulations, donor names must be kept secret. It gives couples with a desire to use artificial insemination the chance. Infertility solutions can be difficult to find in countries that are less developed. This is because about 10% of women struggle to get pregnant or start a family. The market will grow if people are made aware of the issues with infertility.

Regional Analysis

Europe was the largest regional market in 2021, accounting for a 36% share of the global revenue. As the fertility rate has been declining over the years. This decline can be attributed to lifestyle changes and delays in conception. North America was the second largest market. According to the National Center for Health Statistics, there were 62.5 births for every 1000 women. Due to an increased fertility rate and increased awareness of the available treatment options, the Asia Pacific market is expected to grow the fastest in the future.

Key Regions and Countries covered in the report:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

Vitrolife, Rinovum Women’s Health, LLC, Genea Limited, Hi-Tech Solutions, FUJIFILM Orange Scientific, Pride Angel, KITAZATO CORPORATION, and Rocket Medical plc are some of the major players in the market. To strengthen their presence in regional markets, companies focus on the acquisitions of small businesses. JXTGE, for example, announced in March 2018 that Irvine Scientific was sold to FUJIFILM. This acquisition was made to increase its synergy with the company and to maintain its growth within the biomedical sector. In June 2018, the acquisition was complete.

Market Key Players:

• Nikon Instruments Inc.
• Genea Limited
• Rinovum Women’s Health LLC
• Pride Angel
• Hi-Tech Solutions
• Irvine Scientific
• Kitazato Corporation
• Vitrolife
• Other Key Players

For the Artificial Insemination Market research study, the following years have been considered to estimate the market size: